LINC00934

Across TCGA pan-cancer cohorts, LINC00934 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated LINC00934 data layer.

The strongest signal is observed in thymoma (THYM), where higher LINC00934 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC00934 expression acts as an unfavorable survival marker, although some lineages such as MESO and COAD show a favorable association.

THYM, TGCT, and BRCA are the cancer types where LINC00934 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THYM	DFS	Tertile	All	0.432	0.795	<.001	63	view →
TGCT	OS	Tertile	III,IV	0.003	1.000	<.001	54	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	36	view →
LUAD	DFS	Tertile	IV	0.047	0.565	<.001	30	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
MESO	DFS	Tertile	All	0.811	0.342	.019	27	view →
SKCM	OS	Quartile	II,III,IV	0.246	0.472	.004	24	view →
ESCA	DFS	Tertile	II,III,IV	0.122	0.889	.001	23	view →
READ	DFS	Tertile	III,IV	0.438	0.779	.019	18	view →
GBM	DFS	Tertile	All	0.168	0.333	.019	15	view →
COAD	DFS	Tertile	IV	1.000	0.387	.043	9	view →
KICH	OS	Median	II,III,IV	0.951	0.697	.028	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

LINC00934–THYM (DFS)

Open the THYM breakdown →